Data / Drug companies / Solution, concentrate
Companies that list solution, concentrate products: 35 companies and 69 products in the FDA NDC directory
The FDA National Drug Code Directory lists 69 products that are solution, concentrate products from 35 companies. The ten largest listers hold 52.2% of them, and the newest started marketing on April 15, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies
- 35
- Products
- 69
- Drugs by generic name
- 24
- Main marketing category
- Generic drugs (ANDA)
Companies that list solution, concentrate products
Ranked by number of products in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Aqua Medica, S.A. de C.V. | 9 | solution, concentrate | Other unapproved drugs | March 30, 2024 |
| Amneal Pharmaceuticals Private Limited | 5 | solution, concentrate | Generic drugs (ANDA) | July 9, 2025 |
| Hikma Pharmaceuticals USA Inc. | 5 | solution, concentrate | Generic drugs (ANDA) | October 31, 1993 |
| Pilot Chemical Company | 4 | solution, concentrate | Drugs for further processing | March 29, 2023 |
| Teva Pharmaceuticals, Inc. | 3 | solution, concentrate | New drug applications (NDA) | June 1, 2022 |
| Affordable Pharmaceuticals, LLC | 2 | solution, concentrate | New drug applications (NDA) | August 5, 2010 |
| Alexion Pharmaceuticals Inc. | 2 | solution, concentrate | Biologics (BLA) | October 9, 2020 |
| Arxada, LLC | 2 | solution, concentrate | Drugs for further processing | December 6, 2022 |
| Aurobindo Pharma Limited | 2 | solution, concentrate | Generic drugs (ANDA) | January 31, 2017 |
| Azurity Pharmaceuticals, Inc. | 2 | solution, concentrate | New drug applications (NDA) | April 1, 2026 |
| Bayer HealthCare Pharmaceuticals Inc. | 2 | solution, concentrate | New drug applications (NDA) | December 6, 2022 |
| Braintree Laboratories, Inc. | 2 | solution, concentrate | New drug applications (NDA) | August 5, 2010 |
| Institut National Des Radio-Elements | 2 | solution, concentrate | Drugs for further processing | January 2, 2022 |
| Organo Sintesis, S.A. de C.V. | 2 | solution, concentrate | Bulk ingredients | November 1, 2024 |
| Sanofi-Aventis U.S. LLC | 2 | solution, concentrate | Biologics (BLA) | August 3, 2012 |
| Somerset Therapeutics, LLC | 2 | solution, concentrate | Generic drugs (ANDA) | October 23, 2025 |
| Sucampo Pharma Limited Liability Company | 2 | solution, concentrate | Drugs for further processing | April 1, 2010 |
| Wilshire Pharmaceuticals, Inc. | 2 | solution, concentrate | New drug applications (NDA) | April 15, 2026 |
| Advagen Pharma Ltd | 1 | solution, concentrate | Generic drugs (ANDA) | January 31, 2024 |
| Endo USA, Inc. | 1 | solution, concentrate | New drug applications (NDA) | October 1, 1998 |
| Genentech, Inc. | 1 | solution, concentrate | Biologics (BLA) | June 15, 2023 |
| Hikma Pharmaceuticals USA Inc. | 1 | solution, concentrate | Generic drugs (ANDA) | April 23, 2019 |
| Micro Labs Limited | 1 | solution, concentrate | Generic drugs (ANDA) | May 4, 2013 |
| Miyoshi America, Inc. | 1 | solution, concentrate | Drugs for further processing | April 4, 2016 |
| Mylan Pharmaceuticals Inc. | 1 | solution, concentrate | Generic drugs (ANDA) | August 28, 2009 |
| Mylan Pharmaceuticals Inc. | 1 | solution, concentrate | Authorized generics (NDA) | May 15, 2018 |
| Omnivium Pharmaceuticals LLC. | 1 | solution, concentrate | Generic drugs (ANDA) | August 31, 2024 |
| Pai Holdings, LLC DBA Pai Pharma | 1 | solution, concentrate | Generic drugs (ANDA) | September 1, 2010 |
| Patheon Biologics B.V. | 1 | solution, concentrate | Drugs for further processing | February 8, 2020 |
| Polpharma Biologics SA | 1 | solution, concentrate | Bulk ingredients | June 9, 2022 |
| Rising Pharma Holdings, Inc. | 1 | solution, concentrate | Generic drugs (ANDA) | October 31, 2008 |
| Rising Pharma Holdings, Inc. | 1 | solution, concentrate | Generic drugs (ANDA) | December 5, 2011 |
| Sportpharm LLC | 1 | solution, concentrate | Generic drugs (ANDA) | September 1, 1983 |
| Takeda Pharmaceuticals America, Inc. | 1 | solution, concentrate | Biologics (BLA) | July 24, 2006 |
| Viatris Specialty LLC | 1 | solution, concentrate | New drug applications (NDA) | November 21, 2024 |
Drugs most often listed
| Drug | Products here | Companies listing it |
|---|---|---|
| Sertraline hydrochloride | 4 | 55 |
| Lorazepam | 1 | 38 |
| Alprazolam | 1 | 37 |
| Haloperidol | 1 | 32 |
| Fluphenazine hydrochloride | 1 | 29 |
| Cromolyn sodium | 3 | 11 |
| Pemetrexed | 3 | 9 |
| Sodium sulfate, potassium sulfate, magnesium sulfate | 8 | 6 |
| Levalbuterol | 2 | 5 |
| Dexamethasone intensol | 2 | 2 |
| Larotrectinib | 2 | 2 |
| Acid concentrate for hemodialysis | 4 | 1 |
| Hemodialysis grade sodium bicarbonate solution | 3 | 1 |
| Ravulizumab | 2 | 1 |
| Sodium acetate anhydrous | 2 | 1 |
| Ziv-aflibercept | 2 | 1 |
| Cleaning solution for hemodialysis machines | 1 | 1 |
| Desinfectant solution for hemodialysis machine | 1 | 1 |
| Diazepam intensol | 1 | 1 |
| Glofitamab | 1 | 1 |
| Idursulfase | 1 | 1 |
| Prednisone intensol | 1 | 1 |
| Valrubicin | 1 | 1 |
| Valrubicin intravesical solution | 1 | 1 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.